Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Synthomer (LON:SYNT - Get Rating) had its target price cut by equities researchers at JPMorgan Chase & Co. from GBX 350 ($4.23) to GBX 260 ($3.14) in a note issued to investors on Monday, MarketBeat reports. The firm presently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s target price suggests a potential upside of 145.57% from the company's current price.

SYNT has been the subject of a number of other research reports. Barclays reiterated an "equal weight" rating and set a GBX 323 ($3.90) price objective on shares of Synthomer in a research report on Wednesday, August 3rd. Berenberg Bank decreased their target price on shares of Synthomer from GBX 350 ($4.23) to GBX 275 ($3.32) and set a "hold" rating on the stock in a research report on Thursday, August 4th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Synthomer has a consensus rating of "Hold" and a consensus price target of GBX 430.50 ($5.20).Synthomer Price Performance

Shares of Synthomer stock traded down GBX 0.62 ($0.01) during trading on Monday, hitting GBX 105.88 ($1.28). 2,288,698 shares of the company were exchanged, compared to its average volume of 1,428,557. The company has a quick ratio of 0.97, a current ratio of 1.60 and a debt-to-equity ratio of 114.88. Synthomer has a fifty-two week low of GBX 84.35 ($1.02) and a fifty-two week high of GBX 523.50 ($6.33). The stock has a market capitalization of £494.80 million and a price-to-earnings ratio of 573.68. The firm has a 50 day moving average price of GBX 188.60 and a 200 day moving average price of GBX 247.93. Insider Activity at Synthomer

In related news, insider Michael Willome acquired 70,000 shares of the business's stock in a transaction dated Thursday, August 4th. The stock was bought at an average price of GBX 189 ($2.28) per share, for a total transaction of £132,300 ($159,859.84). In related news, insider Lily Liu purchased 2,000 shares of Synthomer stock in a transaction on Monday, August 8th. The stock was bought at an average price of GBX 193 ($2.33) per share, with a total value of £3,860 ($4,664.09). Also, insider Michael Willome purchased 70,000 shares of the company's stock in a transaction dated Thursday, August 4th. The stock was purchased at an average cost of GBX 189 ($2.28) per share, for a total transaction of £132,300 ($159,859.84). Insiders purchased 92,000 shares of company stock worth $17,896,000 in the last 90 days. Synthomer Company Profile (Get Rating)

Synthomer plc operates as a specialty chemicals company. It operates through four segments: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers. The company offers pressure sensitive adhesives, acrylic polymers, acrylic dispersions, saturants, release coatings, and other adhesives; water-based carboxylated styrene butadiene rubber, redispersible powder, flooring adhesive, and additives for construction applications; and impregnation binders, styrene butadiene copolymers, dispersions, polymer binders, and butadiene-based binders for textiles applications.Further ReadingNear-Term Headwinds Send Nike To The Bargain Basement Archer Daniels Midland: Dividend Hero With 49 Years Of IncreasesWill Fully Autonomous Tractors Make Deere the Tesla of Farming? Magna International is Your Auto and EV One-Stop Shop Stock Is the Bond Market Signaling a Market Bottom?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Axel Merk, President and CIO of Merk Investments has three very different stocks he frames within the current market and economic conditions.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.